Related Experiment Video
Updated: Dec 31, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Pregnancy in myositis and scleroderma
Sirajum Munira1, Lisa Christopher-Stine2
1Saint Agnes Hospital Internal Medicine Residency Program, Ascension Health, Postal Address: 10003, Autumn view lane, Ellicott city, Baltimore, MD-21042, USA.
Abstract:
Myositis and scleroderma are both rare autoimmune diseases with female predominance and often occur before and during reproductive years. The rarity of diseases explains the low frequency of concurrent disease and pregnancy. Like other autoimmune diseases, myositis and scleroderma may be more active during pregnancy as well. To date, many patients with myositis and scleroderma can have favorable pregnancy outcomes with careful management. This chapter provides a current overview of pregnancy outcomes in myositis and scleroderma. A major theme that appears to have emerged across these inflammatory diseases is that active maternal disease during pregnancy is associated with adverse pregnancy outcomes, and thus, personalized management is necessary depending on the disease state and comorbidities.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Mitral Valve Prolapse III: Nursing Management
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Oogenesis
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests

